Vext to Announce Financial Results for Q2 2025 on August 20, 2025
Vext Science (OTCQX: VEXTF), a cannabis operator with operations in Arizona and Ohio, has scheduled its Q2 2025 financial results announcement for August 20, 2025, before market open.
The company will host a conference call and webcast on the same day at 8:00 AM ET. Investors can access the call via dial-in numbers or webcast, with a replay available until September 3, 2025.
Vext Science (OTCQX: VEXTF), operatore nel settore della cannabis con attività in Arizona e Ohio, ha programmato la pubblicazione dei risultati finanziari del 2° trimestre 2025 per il 20 agosto 2025, prima dell'apertura dei mercati.
L'azienda terrà lo stesso giorno una conference call e una webcast alle 8:00 ET. Gli investitori potranno partecipare tramite numeri di accesso telefonico o in streaming; la registrazione sarà disponibile in replay fino al 3 settembre 2025.
Vext Science (OTCQX: VEXTF), operador de cannabis con operaciones en Arizona y Ohio, ha programado el anuncio de sus resultados financieros del 2T 2025 para el 20 de agosto de 2025, antes de la apertura del mercado.
La compañía realizará ese mismo día una conferencia telefónica y una transmisión por webcast a las 8:00 AM ET. Los inversores podrán acceder mediante números de marcación o por webcast; habrá una grabación disponible hasta el 3 de septiembre de 2025.
Vext Science (OTCQX: VEXTF)는 애리조나와 오하이오에서 사업을 운영하는 대마(캐나비스) 업체로, 2025년 2분기 실적 발표를 2025년 8월 20일 시장 개장 전에 발표할 예정입니다.
동사는 같은 날 오전 8:00(동부시간)에 콘퍼런스콜과 웹캐스트를 진행합니다. 투자자들은 전화 접속 번호나 웹캐스트로 참여할 수 있으며, 녹음 재청취는 2025년 9월 3일까지 제공됩니다.
Vext Science (OTCQX: VEXTF), opérateur de cannabis présent en Arizona et en Ohio, a programmé l'annonce de ses résultats financiers du 2e trimestre 2025 pour le 20 août 2025, avant l'ouverture des marchés.
La société tiendra le même jour une conférence téléphonique et une webdiffusion à 8h00 (heure de l'Est). Les investisseurs pourront accéder à l'appel via des numéros d'accès ou le webcast; un replay sera disponible jusqu'au 3 septembre 2025.
Vext Science (OTCQX: VEXTF), ein Cannabis-Anbieter mit Standorten in Arizona und Ohio, hat die Veröffentlichung seiner Finanzergebnisse für das 2. Quartal 2025 für den 20. August 2025 geplant, und zwar vor Börsenbeginn.
Das Unternehmen wird am selben Tag um 8:00 Uhr ET eine Telefonkonferenz und ein Webcast abhalten. Investoren können per Einwahlnummer oder Webcast teilnehmen; eine Aufzeichnung steht bis zum 3. September 2025 zur Verfügung.
- None.
- None.
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2025) - Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF) ("Vext" or the "Company"), a U.S.-based cannabis operator with vertical operations in Arizona and Ohio, today announced that it plans to release its financial results for the second quarter ended June 30, 2025, before market open on August 20, 2025.
The Company will host a conference call and webcast on the same day, Wednesday, August 20, 2025, at 08:00 a.m. ET to discuss the financial results.
CONFERENCE CALL DETAILS
Date: August 20, 2025 | Time: 8:00 am E.T.
Participant Dial-in: +1-647-849-3159 or 1-833-752-3966
Replay Dial-in: +1-412-317-0088 or 1-855-669-9658
Conference ID: 10202130
Playback #: 6656822 (Expires on September 3, 2025)
Listen to webcast: https://www.gowebcasting.com/14148
A replay of the conference call and webcast will be available on Vext's investor website following the conclusion of the call. For more details, contact the IR team at investors@vextscience.com.
About Vext Science, Inc.
Vext Science, Inc. is a U.S.-based cannabis operator with vertical operations in Arizona and Ohio. Vext's expertise spans from cultivation through to retail operations in its key markets. Based out of Arizona, Vext owns and operates state-of-the-art cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company manufactures Vapen™, one of the leading THC concentrates, edibles, and distillate cartridge brands in Arizona. Its selection of award-winning products are created with Vext's in-house, high-quality flower and distributed across Arizona and Ohio. Vext's leadership team brings a proven track record of building and operating profitable multi-state operations. The Company's primary focus is to continue growing in its core states of Arizona and Ohio, bringing together cutting-edge science, manufacturing, and marketing to provide a reliable and valuable customer experience while generating shareholder value.
Vext Science, Inc. is listed on the Canadian Securities Exchange under the symbol VEXT and trades on the OTCQX market under the symbol VEXTF. Learn more at www.vextscience.com and connect with Vext on Twitter/X and LinkedIn.
For more details on the Vapen brand:
Vapen website: VapenBrands.com
Instagram: @vapen
Facebook: @vapenbrands
Forward-Looking Statements
Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Vext's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.
Forward-looking statements may include, without limitation, statements regarding the expected filing date of the financial results, future developments and the business and operations of the Vext, all of which are subject to the risk factors contained in Vext's continuous disclosure filed on SEDAR+ at www.sedarplus.ca.
Although Vext has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; being engaged in activities currently considered illegal under U.S. Federal laws; change in laws; reliance on management; requirements for additional financing; competition; hindered market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.
There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.
Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Vext disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Vext does not assume any liability for disclosure relating to any other company mentioned herein.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
Eric Offenberger
Chief Executive Officer
844-211-3725
For further information:
Jonathan Ross, Vext Investor Relations
jon.ross@loderockadvisors.com
416-244-9851
SOURCE: Vext Science, Inc
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261953
FAQ
When will Vext Science (VEXTF) release Q2 2025 earnings?
How can investors join Vext Science's Q2 2025 earnings call?
What time is Vext Science's Q2 2025 earnings call?
How long will Vext Science's Q2 2025 earnings call replay be available?
